A RETROSPECTIVE ANALYSIS OF DRUG UTILIZATION STUDY IN DRUG-RESISTANT TUBERCULOSIS AT TERTIARY CARE HOSPITAL, GUJARAT

VIJITA SHAH; CHETNA PATEL; JIGAR CHOTALIYA; BHARGAVI PATEL

doi:10.22159/ijpps.2025v17i4.53513

Authors

VIJITA SHAH Department of Pharmacology, Dr Kiran C Patel Medical College and Research Institute, Bharuch, Gujarat, India https://orcid.org/0009-0005-0506-8316
CHETNA PATEL Department of Pharmacology, Government Medical College, Surat, Gujarat, India
JIGAR CHOTALIYA Department of Pharmacology, Pacific Medical College and Hospital, Udaipur, Rajasthan, India
BHARGAVI PATEL Department of Pharmacology, Dr M K Shah Medical College and Research Centre, Ahmedabad, Gujarat, India

DOI:

https://doi.org/10.22159/ijpps.2025v17i4.53513

Keywords:

Government of India, Tuberculosis, Drug utilization, Defined daily dose, Prescribed daily dose, Essential medicine

Abstract

Objective: The point of this observational study was to look at how inpatients at our tertiary care facility used medications. The goal was to find ways to improve prescription practices for people with drug-resistant tuberculosis.

Methods: The respiratory ward medical record department serves as the retrospective source of data. We enrolled a total of 301 patients with drug-resistant tuberculosis. We assess drug utilization data using the World Health Organization Anatomical Therapeutic Chemical/Defined Daily Dose approach. We analyzed prescriptions using World Health Organization core drug indicators.

Results: Adherence to international standards was demonstrated by the prescription of most antibiotics at dosages consistent with the recommended daily dose. Antibiotic polypharmacy (100%) was common with Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (64.1%), proton pump inhibitors (61.5%), vitamins and minerals (77.7%), and generic names (92%) that were frequently provided with oral medications (77%). The National List of Essential Medicines 2022 contained information on approximately 95% of all prescribed drugs.

Conclusion: Drug costs were significantly impacted by the fact that antibiotics were the most often-given drugs, accompanied by vitamins and minerals, NSAIDs, and proton pump inhibitors. Limiting the use of more costly, recent antibiotics, branded medications, and the number of medications given can drastically lower the cost of drug therapy.

Downloads

Download data is not yet available.

References

Introduction to drug utilization research. WHOCC. 2003;92(4):156234.

National strategic plan for tuberculosis elimination 2017-2025. New Delhi; 2017. Available from: https://tbcindia.gov.in/WriteReadData/NSPDraft20.02.20171.pdf. [Last accessed on 11 Mar 2025].

Dookie N, Ngema SL, Perumal R, Naicker N, Padayatchi N, Naidoo K. The changing paradigm of drug-resistant tuberculosis treatment: successes, pitfalls, and future perspectives. Clin Microbiol Rev. 2022;35(4):e0018019. doi: 10.1128/cmr.00180-19, PMID 36200885.

WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment; 2024. Available from: http://www.whocc.no/filearchive/publications/2024guidelines.pdf. [Last accessed on 11 Mar 2025].

Koristkova B, Grundmann M, Brozmanova H. Differences between prescribed daily doses and defined daily doses of antiepileptics-therapeutic drug monitoring as a marker of the quality of the treatment. Int J Clin Pharmacol Ther. 2006;44(9):438-42. doi: 10.5414/cpp44438, PMID 16995332.

Muller A, Monnet DL, Talon D, Henon T, Bertrand X. Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol. 2006;61(5):585-91. doi: 10.1111/j.1365-2125.2006.02605.x, PMID 16669851.

Duarte Ramos F, Cabrita J. Using a pharmaco-epidemiological approach to estimate diabetes type 2 prevalence in portugal. Pharmacoepidemiol Drug Saf. 2006;15(4):269-74. doi: 10.1002/pds.1186, PMID 16294365.

Grimmsmann T, Himmel W. Discrepancies between prescribed and defined daily doses: a matter of patients or drug classes? Eur J Clin Pharmacol. 2011;67(8):847-54. doi: 10.1007/s00228-011-1014-7, PMID 21544512.

Ghosh BN, Mitra J, Das KK. Prescription habits of physicians in an urban locality. Indian J Public Health. 1987;31(2):120-8. PMID 3453359.

Ahmad SR, Bhutta ZA. A survey of paediatric prescribing and dispensing in Karachi. J Pak Med Assoc. 1990;40(6):126-30. PMID 2118192.

Phadke AR. The quality of prescribing in an Indian District. Natl Med J India. 1996;9(2):60-5. PMID 8857039.

Das NP, Saha NN, Roy ND. Drug utilization study of psychotropic drugs in psychiatry outdoor patients at A Tertiary Care Hospital. Asian J Pharm Clin Res. 2024:56-60. doi: 10.22159/ajpcr.2024v17i7.51781[PubMed].

Mandal A, Gangopadhyay T, Mandal S. Drug utilization study in a radiotherapy unit of a tertiary care teaching hospital in rural West Bengal, India. Asian J Pharm Clin Res. 2022b;15(11):126-30. doi: 10.22159/ajpcr.2022.v15i11.45709.

Naik PS, Kandra NV, Bai KS. A prospective, observational drug utilization study in the dermatology outpatient department of a government hospital, nandyal, Andhra Pradesh. Int J Curr Pharm Sci. 2024;16(6):89-92. doi: 10.22159/ijcpr.2024v16i6.5087.

Hazra A, Tripathi SK, Alam MS. Prescribing and dispensing activities at the health facilities of a non-governmental organization. Natl Med J India. 2000;13(4):177-82. PMID 11002683.

Biswal S, Mishra P, Malhotra S, Puri GD, Pandhi P. Drug utilization pattern in the intensive care unit of a Tertiary Care Hospital. J Clin Pharmacol. 2006;46(8):945-51. doi: 10.1177/0091270006289845, PMID 16855079.

Choure MK, Jadhav RR, Padwal SLP. Drug utilization study in neonatal intensive care unit at rural Tertiary Care Hospital. Asian J Pharm Clin Res. 2017 Apr 1;10(4):102-4. doi: 10.22159/ajpcr.2017.v10i4.16111.

Singh I, Mittal R, Shafiq N, Bharati B, Nigah RK, Pandhi P. A drug utilization study to provide background data for bringing amendments in the drug dispensing policy of a pediatric referral center. Pharmacoepidemiol Drug Saf. 2010;19(4):393-9. doi: 10.1002/pds.1832, PMID 20020440.

Dhamija P, Bansal D, Srinivasan A, Bhalla A, Hota D, Chakrabarti A. Patterns of prescription drug use and incidence of drug-drug interactions in patients reporting to medical emergency. Fundam Clin Pharmacol. 2013;27(2):231-7. doi: 10.1111/j.1472-8206.2011.00990.x, PMID 21895763.

National List of Essential Medicine; 2022. http://www.cdsco.nic.in/nedl.pdf. [Last accessed on 11 Mar 2025]

Bro F, Mabeck CE. Use of antibiotics in general practice in Denmark. Prescribed daily dose, duration of treatment and number of treatments in general practice. Scand J Prim Health Care. 1986;4(2):101-4. doi: 10.3109/02813438609014811, PMID 3726323.

Gyssens IC. Quality measures of antimicrobial drug use. Int J Antimicrob Agents. 2001;17(1):9-19. doi: 10.1016/s0924-8579(00)00208-9, PMID 11137643.

Mansouri MD, Cadle RM, Agbahiwe SO, Musher DM. Impact of an antibiotic restriction program on antibiotic utilization in the treatment of community-acquired pneumonia in a veterans affairs medical center. Infection. 2011;39(1):53-8. doi: 10.1007/s15010-010-0078-0, PMID 21318422.

Westphal JF, Jehl F, Javelot H, Nonnenmacher C. Enhanced physician adherence to antibiotic use guidelines through increased availability of guidelines at the time of drug ordering in hospital setting. Pharmacoepidemiol Drug Saf. 2011;20(2):162-8. doi: 10.1002/pds.2078, PMID 21254287.

Haas JS, Phillips KA, Gerstenberger EP, Seger AC. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med. 2005;142(11):891-7. doi: 10.7326/0003-4819-142-11-200506070-00006, PMID 15941695.

Shrank WH, Hoang T, Ettner SL, Glassman PA, Nair K, DeLapp D. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch Intern Med. 2006;166(3):332-7. doi: 10.1001/archinte.166.3.332, PMID 16476874.

Taxis K, Barber N. Ethnographic study of incidence and severity of intravenous drug errors. BMJ. 2003;326(7391):684. doi: 10.1136/bmj.326.7391.684, PMID 12663404.

WHO Essential medicine list. Available from: http://www.who.int/medicines/publications/08_english_indexfinal_EML22.pdf. [Last accessed on 11 Mar 2025].

Chaudhury RR, Parameswar R, Gupta U, Sharma S, Tekur U, Bapna JS. Quality medicines for the poor: experience of the Delhi programme on rational use of drugs. Health Policy Plan. 2005;20(2):124-36. doi: 10.1093/heapol/czi015, PMID 15746221.

Junius Walker U, Theile G, Hummers Pradier EH. Prevalence and predictors of polypharmacy among older primary care patients in germany. Fam Pract. 2007;24(1):14-9. doi: 10.1093/fampra/cml067, PMID 17164234.

Kojima T, Akishita M, Nakamura T, Nomura K, Ogawa S, Iijima K. Association of polypharmacy with fall risk among geriatric outpatients. Geriatr Gerontol Int. 2011;11(4):438-44. doi: 10.1111/j.1447-0594.2011.00703.x, PMID 21545384.

Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Med (Baltim). 2010;89(5):295-9. doi: 10.1097/MD.0b013e3181f15efc, PMID 20827106.